Trials / Completed
CompletedNCT00532506
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SK-0403 |
Timeline
- First posted
- 2007-09-20
- Last updated
- 2008-10-10
Locations
10 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00532506. Inclusion in this directory is not an endorsement.